These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 26938120
1. Novel Combretastatin-2-aminoimidazole Analogues as Potent Tubulin Assembly Inhibitors: Exploration of Unique Pharmacophoric Impact of Bridging Skeleton and Aryl Moiety. Chaudhary V, Venghateri JB, Dhaked HP, Bhoyar AS, Guchhait SK, Panda D. J Med Chem; 2016 Apr 14; 59(7):3439-51. PubMed ID: 26938120 [Abstract] [Full Text] [Related]
2. Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure⁻Activity Relations of New Inhibitors of HDAC and/or Tubulin Function. Schmitt F, Gosch LC, Dittmer A, Rothemund M, Mueller T, Schobert R, Biersack B, Volkamer A, Höpfner M. Int J Mol Sci; 2019 Jan 17; 20(2):. PubMed ID: 30658435 [Abstract] [Full Text] [Related]
5. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents. Zhou P, Liang Y, Zhang H, Jiang H, Feng K, Xu P, Wang J, Wang X, Ding K, Luo C, Liu M, Wang Y. Eur J Med Chem; 2018 Jan 20; 144():817-842. PubMed ID: 29306206 [Abstract] [Full Text] [Related]
7. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents. Kim ND, Park ES, Kim YH, Moon SK, Lee SS, Ahn SK, Yu DY, No KT, Kim KH. Bioorg Med Chem; 2010 Oct 01; 18(19):7092-100. PubMed ID: 20810285 [Abstract] [Full Text] [Related]
8. Combretastatin A-4 Analogue: A Dual-Targeting and Tubulin Inhibitor Containing Antitumor Pt(IV) Moiety with a Unique Mode of Action. Huang X, Huang R, Gou S, Wang Z, Liao Z, Wang H. Bioconjug Chem; 2016 Sep 21; 27(9):2132-48. PubMed ID: 27494235 [Abstract] [Full Text] [Related]
12. Microwave-assisted synthesis and biological evaluation of 3,4-diaryl maleic anhydride/N-substituted maleimide derivatives as combretastatin A-4 analogues. Guan Q, Zuo D, Jiang N, Qi H, Zhai Y, Bai Z, Feng D, Yang L, Jiang M, Bao K, Li C, Wu Y, Zhang W. Bioorg Med Chem Lett; 2015 Feb 01; 25(3):631-4. PubMed ID: 25529737 [Abstract] [Full Text] [Related]
14. Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers. Kamal A, Shaik B, Nayak VL, Nagaraju B, Kapure JS, Shaheer Malik M, Shaik TB, Prasad B. Bioorg Med Chem; 2014 Oct 01; 22(19):5155-67. PubMed ID: 25192811 [Abstract] [Full Text] [Related]
15. Combretastatin linked 1,3,4-oxadiazole conjugates as a Potent Tubulin Polymerization inhibitors. Kamal A, Srikanth PS, Vishnuvardhan MV, Kumar GB, Suresh Babu K, Hussaini SM, Kapure JS, Alarifi A. Bioorg Chem; 2016 Apr 01; 65():126-36. PubMed ID: 26943479 [Abstract] [Full Text] [Related]
17. Synthesis and evaluation of diaryl sulfides and diaryl selenide compounds for antitubulin and cytotoxic activity. dos Santos Edos A, Hamel E, Bai R, Burnett JC, Tozatti CS, Bogo D, Perdomo RT, Antunes AM, Marques MM, Matos Mde F, de Lima DP. Bioorg Med Chem Lett; 2013 Aug 15; 23(16):4669-73. PubMed ID: 23810282 [Abstract] [Full Text] [Related]
18. Discovery of potent cytotoxic ortho-aryl chalcones as new scaffold targeting tubulin and mitosis with affinity-based fluorescence. Zhu C, Zuo Y, Wang R, Liang B, Yue X, Wen G, Shang N, Huang L, Chen Y, Du J, Bu X. J Med Chem; 2014 Aug 14; 57(15):6364-82. PubMed ID: 25061803 [Abstract] [Full Text] [Related]
20. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity. Ducki S, Rennison D, Woo M, Kendall A, Chabert JF, McGown AT, Lawrence NJ. Bioorg Med Chem; 2009 Nov 15; 17(22):7698-710. PubMed ID: 19837593 [Abstract] [Full Text] [Related] Page: [Next] [New Search]